Marc Funk
Direktor/Vorstandsmitglied bei RECIPHARM AB (PUBL)
Ursprung des Netzwerks ersten Grades von Marc Funk
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 37 | |
| Holding Company | Biotechnology | 25 | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.
10
| Subsidiary | Medical Specialties | 10 |
Chime Biologics Ltd.
 Chime Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Chime Biologics Ltd. is a leading Contract Development and Manufacturing Organization (CDMO) that provides customer-centric and cost-effective outsourcing services for biopharmaceutical development and manufacturing. The company is based in Wuhan, China, and its world's first GE Kubio facility is located at Wuhan's Bio-Lake Biotech Industry Development Zone, with a clear path to expand the total capacity up to 140,000+ liters in the near future. The Chinese company has introduced the world's first modular biopharmaceutical plant, Kubio, which empowers its partners' success in biologics from cell line development to commercial manufacturing. Chime Biologics is committed to making cutting-edge biomedicines affordable and accessible to all patients, fulfilling its commitment to human health. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 certified and has been providing customers with clinical materials for pre-clinical and clinical stages worldwide since 2016.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Bionter AG
 Bionter AG Wholesale DistributorsDistribution Services Bionter AG is a start-up that specializes in providing particle counters for the pharmaceutical and biotechnology industries. The company is based in Riehen, Switzerland, and Tobias Werk has been the CEO since 2020. The Swiss company is dedicated to revolutionizing the industry with innovative breakthrough developments that increase quality, safety, and cost-effectiveness.
3
| Holding Company | Wholesale Distributors | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marc Funk
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Lonza Biologics Plc
 Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Chairman President Chief Executive Officer Director/Board Member | |
scienceindustries
 scienceindustries Miscellaneous Commercial ServicesCommercial Services scienceindustries operates as Swiss Business Association Chemistry Pharma Life Sciences. The firm represents the economic and political interests of its member companies. It also promotes the global competitiveness of its member companies by promoting an innovation-friendly environment and providing services for its members. The company was founded on December 23, 1944 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member President | |
| AUTO ITALIA HOLDINGS LIMITED | Specialty Stores | Director/Board Member Chief Executive Officer Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Imperial College London | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| NESTLÉ S.A. | Food: Major Diversified | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Kiel | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| UCB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| CONSORT MEDICAL PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| JHL BIOTECH, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cognis BV
 Cognis BV Chemicals: SpecialtyProcess Industries Cognis BV manufactures chemicals based natural oils and animal fats. It develops products and solutions for personal care, home care, and nutrition products for industrial markets. The company was founded in December 1999 is headquartered in Roermond, the Netherlands. | Chemicals: Specialty | Corporate Officer/Principal Corporate Officer/Principal | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Graduate Degree | |
| École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree Corporate Officer/Principal | |
Economiesuisse
 Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member President | |
GenScript Corp.
 GenScript Corp. BiotechnologyHealth Technology GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
EQT Partners AB
 EQT Partners AB Investment ManagersFinance EQT Partners AB (EQT Partners) is a private equity subsidiary of EQT AB founded in 1994 by Yngve Conni Jonsson. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor Private Equity Investor | |
| NOVARTIS AG | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| QIAGEN N.V. | Medical Specialties | Director/Board Member Director/Board Member | |
| Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman General Counsel | |
Lonza Houston, Inc.
 Lonza Houston, Inc. Pharmaceuticals: OtherHealth Technology Lonza Houston, Inc. produces viral-based therapeutics. The company was founded in 1995 and is headquartered in Houston, TX. | Pharmaceuticals: Other | Chairman Chief Executive Officer | |
Wasserburger Arzneimittelwerk GmbH
 Wasserburger Arzneimittelwerk GmbH Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Wasserburger Arzneimittelwerk GmbH is a German company that manufactures injectable pharmaceuticals. The company is based in Wasserburg am Inn, Germany. The company was founded in 1989. The CEO is Michael Isele. Wasserburger Arzneimittelwerk was acquired by Recipharm AB from Hospira, Inc. on January 31, 2010. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
KPCB China Fund II LP
 KPCB China Fund II LP Investment ManagersFinance KPCB China Fund II LP seeks investment opportunities in companies located in China. The fund focuses on companies operating in the fields of health technology, industrial services, and technology services sectors.. It provides financing for seed, early and later-stage capital requirements. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| STALLERGENES | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
| University of St. Gallen | College/University | Masters Business Admin Undergraduate Degree | |
| Recipharm Stockholm AB | Director/Board Member Director/Board Member | ||
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| University of Hamburg | College/University | Undergraduate Degree Doctorate Degree | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SHL Medical AG
 SHL Medical AG Medical SpecialtiesHealth Technology SHL Medical AG engages in the design, development, and manufacture of advanced drug delivery devices, as well as provides final assembly, labeling, and packaging services for pharma and biotech companies. Its products include autoinjectors, pen injectors, inhaler systems, pressure mattress systems, patient lifting slings, medical soft goods. The firm also offers design-to-build and contract manufacturing of products, such as laboratory handling equipment, neurosurgical devices, and industrial equipment. The company was founded by Roger Samuelsson and Martin Jelf in 1989 and is headquartered in Zug, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member | |
| Swedish Pharmaceutical Society | Corporate Officer/Principal Chairman | ||
| SYNGENTA | Chemicals: Agricultural | Director/Board Member General Counsel | |
Swiss-American Chamber of Commerce
 Swiss-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| North Carolina State University | College/University | Undergraduate Degree Doctorate Degree | |
| MEDA AB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HENKEL AG & CO. KGAA | Household/Personal Care | Corporate Officer/Principal Human Resources Officer | |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
Binx Health Ltd.
 Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Graduate Degree | |
Project HOPE-The-People-To-People HealthFoundation, Inc.
 Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree |
Statistik
International
| Schweiz | 16 |
| Schweden | 11 |
| Vereinigte Staaten | 9 |
| Deutschland | 6 |
| Vereinigtes Königreich | 5 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Process Industries | 4 |
| Finance | 4 |
Operativ
| Director/Board Member | 367 |
| Corporate Officer/Principal | 167 |
| Chairman | 118 |
| Chief Executive Officer | 76 |
| Independent Dir/Board Member | 62 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Zuie Chin Huang | 40 |
| Reinhard Vogt | 40 |
| Richard Sykes | 37 |
| Carl-Johan Spak | 35 |
| Thomas Ebeling | 33 |
| Werner J. Bauer | 29 |
| Margot A. Scheltema | 24 |
| Stefan Borgas | 22 |
| Christoph Mäder | 21 |
| Hans Jörg Reinhardt | 20 |
| Grégory Behar | 20 |
| Mark Royston Quick | 19 |
| Jürgen B. Steinemann | 19 |
| Frits van Dijk | 19 |
| Rolf Soiron | 18 |
